AAS
CRVO icon

Avantax Advisory Services’s CervoMed CRVO Stock Holding History

Avantax Advisory Services’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$164K Buy
26,087
+103
+0.4% +$878 ﹤0.01% 2238
2025
Q1 		$238K Buy
+25,984
New +$99K ﹤0.01% 1996

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Avantax Advisory Services's CRVO Position: Q2 2025 in Review

Avantax Advisory Services increased its CervoMed (CRVO) stake by 0.4% in Q2 2025, buying an estimated $878 and bringing the position to 26,087 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Avantax Advisory Services first reported a position in CRVO in Q1 2025 and has held it in 2 quarters since. The position peaked at $238K in Q1 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

  • Avantax Advisory Services held 26,087 shares of CervoMed worth $164K as of Q2 2025.
  • Avantax Advisory Services bought 103 CervoMed shares in Q2 2025, an estimated $878.
  • CervoMed made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2238 holding.
  • Avantax Advisory Services first reported a position in CervoMed in Q1 2025 and has held it in 2 quarters since.
  • Avantax Advisory Services's CervoMed position peaked at $238K in Q1 2025.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.